Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · see citing works

Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease

The Parkinson Study Group (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,222 · see citing works

HANDBOOK OF EXPERIMENTAL PHARMACOLOGY

Reichlin, S. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196911000-00008 · Cited by 1,139 · see citing works

Trace amines: Identification of a family of mammalian G protein-coupled receptors

Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912 · see citing works

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

The Parkinson Study Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212004 · Cited by 912 · see citing works

Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor

Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651 · see citing works

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

Tetrud, J. W., & Langston, J. W. (1989) · Science · doi:10.1126/science.2502843 · Cited by 635 · see citing works

Transdermal Selegiline in Major Depression: A Double-Blind, Placebo-Controlled, Parallel-Group Study in Outpatients

Bodkin, J. A., & Amsterdam, J. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1869 · Cited by 318 · see citing works

IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE

Birkmayer, W., Riederer, P. F., Ambrozi, L., & Youdim, M. B. H. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91940-7 · Cited by 296 · see citing works

Selegiline as initial treatment in de novo parkinsonian patients

Myllylä, V. V., Sotaniemi, K. A., Vuorinen, J. A., & Heinonen, E. H. (1992) · Neurology · doi:10.1212/wnl.42.2.339 · Cited by 171 · see citing works

Following the trace of elusive amines

Premont, R. T., Gainetdinov, R. R., & Caron, M. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181356198 · Cited by 160 · see citing works

Depression in Parkinson's disease: a biochemical and organic viewpoint.

Mayberg, H. S., & Solomon, D. H. (1995) · PubMed · Cited by 149 · see citing works

A Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Selegiline Transdermal System Without Dietary Restrictions in Patients With Major Depressive Disorder

Amsterdam, J. D. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0216 · Cited by 147 · see citing works

Depression in Parkinson??s Disease

Tom, T., & Cummings, J. L. (1998) · Drugs & Aging · doi:10.2165/00002512-199812010-00006 · Cited by 117 · see citing works

Trace Amines and the Brain

Curzon, G. (1977) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.40.8.831 · Cited by 114 · see citing works

Does selegiline modify the progression of early Parkinson's disease? Results from a five‐year study

Larsen, J. O., Boas, J., Erdal, J. E., & Norwegian‐Danish Study Group (1999) · European Journal of Neurology · doi:10.1046/j.1468-1331.1999.650539.x · Cited by 106 · see citing works

L-Deprenil, A Selective Monoamine Oxidase Type B Inhibitor, in the Treatment of Depression: A Double Blind Evaluation

Mendlewicz, J., & Youdim, M. B. H. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.142.5.508 · Cited by 93 · see citing works

Does phenylethylamine act as an endogenous amphetamine in some patients?

Janssen, P., Leysen, J., Megens, A., & Awouters, F. (1999) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001522 · Cited by 88 · see citing works

L-deprenyl, a selective monoamine oxidase type-b inhibitor in endogenous depression

Mann, J. J., & Gershon, S. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90350-1 · Cited by 86 · see citing works

l-Deprenyl in Atypical Depressives

Quitkin, F. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190051006 · Cited by 86 · see citing works

Sustained antidepressant effect of PEA replacement

SABELLI, H. C., Fink, P., FAWCETT, J. A., & Tom, C. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.2.168 · Cited by 80 · see citing works

Specific [3H]β-phenylethylamine binding sites in rat brain

Hauger, R. L., Skolnick, P., & Paul, S. M. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90301-6 · Cited by 79 · see citing works

Phenylethylamine modulation of affect: therapeutic and diagnostic implications

SABELLI, H. C., & Javaid, J. I. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.1.6 · Cited by 77 · see citing works

(‐)Deprenyl (Selegiline), a Catecholaminergic Activity Enhancer (CAE) Substance Acting in the Brain

Knull, J. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01399.x · Cited by 75 · see citing works

L-deprenyl plus l-phenylalanine in the treatment of depression

Birkmayer, W., Riederer, P. F., Linauer, W., & Knoll, J. E. (1984) · Journal of Neural Transmission · doi:10.1007/bf01249880 · Cited by 74 · see citing works

The trace amines and their acidic metabolites in depression — an overview

Davis, B. A., & Boulton, A. A. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90022-1 · Cited by 74 · see citing works

Tyramine Content of Previously Restricted Foods in Monoamine Oxidase Inhibitor Diets

Walker, S. E., Shulman, K. I., Tailor, S. A. N., & Gardner, D. M. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00007 · Cited by 64 · see citing works

Selegiline in de novo parkinsonian patients: The French selegiline multicenter trial (FSMT)

Allain, H., Cougnard, J., & Neukirch, H. C. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05024.x · Cited by 60 · see citing works

Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain

Knoll, J. E., Miklya, I., Knoll, B., Markó, R., & Rácz, D. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00204-4 · Cited by 57 · see citing works

Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements.

SABELLI, H. C., Fawcett, J., Gusovsky, F., Javaid, J. I., Wynn, P., Edwards, J., Jeffriess, H., & Kravitz, H. M. (1986) · PubMed · Cited by 55 · see citing works

Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rationale for prophylactic (-)deprenyl (selegiline) medication

Knoll, J. E., & Miklya, I. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00494-d · Cited by 54 · see citing works

(−)1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

Knoll, J. E., Yoneda, F., Knoll, B., Ohde, H., & Miklya, I. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702995 · Cited by 53 · see citing works

(−)Deprenyl and (−)1-phenyl-2-propylaminopentane, [(−) PPAP] act primarily as potent stimulants of action potential — transmitter release coupling in the catecholaminergic neurons

Knoll, J. E., Miklya, I., Knoll, B., Markó, R., & Kelemen, K. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00014-8 · Cited by 50 · see citing works

A placebo-controlled trial of L-deprenyl in atypical depression.

McGrath, P. J., Jw, S., Harrison, W. M., Wager, S., En, N., & Quitkin, F. M. (1989) · PubMed · Cited by 45 · see citing works

Structure–activity studies leading to (−)1-(Benzofuran-2-yl)-2-propylaminopentane, ((−)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of Catecholamines and Serotonin in the brain

Yoneda, F. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00002-5 · Cited by 40 · see citing works

DHEA, PREG and Their Sulphate Derivatives on Plasma and Brain After CRH and ACTH Administration

Torres, J. M., & Ortega, E. (2003) · Neurochemical Research · doi:10.1023/a:1024276328127 · Cited by 38 · see citing works

Antiaging Compounds: (‐)Deprenyl (Selegiline) and (‐)1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane, [(‐)BPAP], a Selective Highly Potent Enhancer of the Impulse Propagation Mediated Release of Catecholamines and Serotonin in the Brain

Knoll, J. E. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00202.x · Cited by 36 · see citing works

Retrospective Study of Selegiline-Antidepressant Drug Interactions and a Review of the Literature

Ritter, J. L., & Alexander, B. (1997) · Annals of Clinical Psychiatry · doi:10.3109/10401239709147768 · Cited by 35 · see citing works

Retrospective study of selegiline-antidepressant drug interactions and a review of the literature.

Ritter, J. L., & ALEXANDER, B. K. (1997) · Annals of Clinical Psychiatry · doi:10.1023/a:1026222106851 · Cited by 34 · see citing works

(−)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release

Shimazu, S., Takahata, K., Katsuki, H., Tsunekawa, H., Tanigawa, A., Yoneda, F., Knoll, J. E., & Akaike, A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01040-8 · Cited by 32 · see citing works

Memories of my 45 Years in Research

Knoll, J. E. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb00326.x · Cited by 30 · see citing works

Binding sites for brain trace amines

Nguyen, T., & Juorio, A. V. (1989) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711411 · Cited by 26 · see citing works

The novel catecholaminergic and serotoninergic activity enhancer R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes

Ohta, K., Ohta, M., Mizuta, I., Fujinami, A., Shimazu, S., Sato, N., Yoneda, F., Hayashi, K., & Kuno, S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00461-5 · Cited by 26 · see citing works

Enhancer substances: Selegiline and R-(–)-1-(benzofuran-2-yl)-2-propylaminopentane [(–)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes

Shimazu, S., Tanigawa, A., Sato, N., Yoneda, F., Hayashi, K., & Knoll, J. E. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00191-7 · Cited by 25 · see citing works

Selegiline hydrochloride and cognition

Lees, A. J. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05027.x · Cited by 25 · see citing works

Enantioselective synthesis and absolute configuration of (−)-1-(benzofuran-2-yl)-2-propylaminopentane, ((−)-BPAP), a highly potent and selective catecholaminergic activity enhancer

Oka, T. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00341-2 · Cited by 23 · see citing works

Tryptamine receptors: neurochemical and electrophysiological evidence for postsynaptic and functional binding sites

Nguyen, T., Paterson, I. A., Juorio, A. V., Greenshaw, A. J., & Boulton, A. A. (1989) · Brain Research · doi:10.1016/0006-8993(89)91539-4 · Cited by 22 · see citing works

Enhancer Regulation/Endogenous and Synthetic Enhancer Compounds: A Neurochemical Concept of the Innate and Acquired Drives

Knoll, J. E. (2003) · Neurochemical Research · doi:10.1023/a:1024224311289 · Cited by 21 · see citing works

(−)1-(Benzofuran-2-yl)-2-propylaminopentane Shows Survival Effect on Cortical Neurons Under Serum-Free Condition Through Sigma Receptors

Hamabe, W., Fujita, R., Yasusa, T., Yoneda, F., Yoshida, A., & Ueda, H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007050808754 · Cited by 18 · see citing works

The clinical potential of Deprenyl in neurologic and psychiatric disorders

Kuhn, W., & Müller, T. (1996) · Springer eBooks · doi:10.1007/978-3-7091-7494-4_8 · Cited by 17 · see citing works

A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), α-tocopherol was ineffective in the DATATOP study

Miklya, I., Knoll, B., & Knoll, J. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00174-7 · Cited by 16 · see citing works

Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane, (−)-BPAP

Knoll, J. E., Miklya, I., & Knoll, B. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01969-0 · Cited by 16 · see citing works

High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers

Knoll, J. E., Knoll, B., & Miklya, I. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00037-9 · Cited by 15 · see citing works

Analysis of the effect of (-)-BPAP, a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

Miklya, I., & Knoll, J. E. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00197-8 · Cited by 12 · see citing works

1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (−)-BPAP in the shuttle box and leaves the effect of (−)-deprenyl unchanged

Knoll, J. E., Miklya, I., Knoll, B., Yasusa, T., Shimazu, S., & Yoneda, F. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01968-9 · Cited by 10 · see citing works

Monoamine Oxidase Inhibitors as Anti-Depressant Drugs and as Adjunct to L-Dopa Therapy of Parkinson’s Disease

Youdim, M. B. H. (1980) · Springer eBooks · doi:10.1007/978-3-7091-8582-7_17 · Cited by 9 · see citing works

The l-DOPA-sparing effect of R-(–)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(–)-BPAP] in reserpine-pretreated rats

Shimazu, S., Tamashiro, A., Yoneda, F., & Knoll, J. E. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02411-6 · Cited by 9 · see citing works

An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats

Miklya, I., Knoll, B., & Knoll, J. E. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00192-9 · Cited by 7 · see citing works

Functional interactions of 2-phenylethylamine and of tryptamine with brain catecholamines: Implications for psychotherapeutic drug action

Greenshaw, A. J. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90131-0 · Cited by 7 · see citing works

Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.

(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2 · see citing works

[Parkinson's disease].

Miyoshi, K. (2001) · PubMed · Cited by 2 · see citing works

Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health

Oliphant, K., & Allen-Vercoe, E. (2019) · Microbiome · doi:10.1186/s40168-019-0704-8 · Cited by 1,327 · see citing works

The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling

Mazzoli, R., & Pessione, E. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01934 · Cited by 383 · see citing works

Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines

Pessione, E., & Cirrincione, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00876 · Cited by 333 · see citing works

Trace amine-associated receptor 1—Family archetype or iconoclast?

Grandy, D. K. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.007 · Cited by 196 · see citing works

Tyramine and Phenylethylamine Biosynthesis by Food Bacteria

Marcobal, A. M., Rivas, B. D. L., Landete, J. M., Tabera, L., & Múñoz, R. (2012) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.500545 · Cited by 197 · see citing works

The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases

Berry, M. D. (2007) · Reviews on Recent Clinical Trials · doi:10.2174/157488707779318107 · Cited by 132 · see citing works

Synephrine: From trace concentrations to massive consumption in weight-loss

Rossato‐Grando, L. G., Costa, V. M., Limberger, R. P., Bastos, M. D. L., & Remião, F. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.11.007 · Cited by 116 · see citing works

Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine

Arbo, M. D., Larentis, E. R., Linck, V. M., Aboy, A. L., Pimentel, A. L., Henriques, A. T., Dallegrave, E., García, S. C., Leal, M. B., & Limberger, R. P. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.04.037 · Cited by 105 · see citing works

The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): A brief review

Corkery, J., Durkin, E., Elliott, S. P., Schifano, F., & Ghodse, A. H. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.022 · Cited by 104 · see citing works

Nanopipet-Based Liquid–Liquid Interface Probes for the Electrochemical Detection of Acetylcholine, Tryptamine, and Serotonin via Ionic Transfer

Colombo, M. L., Sweedler, J. V., & Shen, M. (2015) · Analytical Chemistry · doi:10.1021/ac504151e · Cited by 99 · see citing works

Palladium-Catalyzed Cross-Coupling of N-Sulfonylaziridines with Boronic Acids

Duda, M. L., & Michael, F. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja410686v · Cited by 96 · see citing works

Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond

D’Andrea, G., & Léon, A. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0267-8 · Cited by 86 · see citing works

First genetic characterization of a bacterial β-phenylethylamine biosynthetic enzyme in Enterococcus faecium RM58: Phenylethylamine production by Enterococcus faecium

Marcobal, A., De Las Rivas, B., & Muñoz, R. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00206.x · Cited by 83 · see citing works

The gut microbiome-immune axis as a target for nutrition-mediated modulation of food allergy

Wang, Z., Zhong, J., Meng, X., Gao, J., Li, H., Sun, J., Li, X., & Chen, H. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.05.021 · Cited by 81 · see citing works

First evidence of a membrane‐bound, tyramine and β‐phenylethylamine producing, tyrosine decarboxylase in <i>Enterococcus faecalis</i>: A two‐dimensional electrophoresis proteomic study

Pessione, E., Pessione, A., Lamberti, C., Coïsson, D. J., Riedel, K., Mazzoli, R., Bonetta, S., Eberl, L., & Giunta, C. (2009) · PROTEOMICS · doi:10.1002/pmic.200800780 · Cited by 72 · see citing works

Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms

Li, J., Sun, C., Cai, W., Li, J., Rosen, B. P., & Chen, J. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108396 · Cited by 68 · see citing works

Receptors of mammalian trace amines

Lewin, A. H. (2006) · The AAPS Journal · doi:10.1208/aapsj080116 · Cited by 59 · see citing works

Late-Stage Functionalization of Aromatic Acids with Aliphatic Aziridines: Direct Approach to Form β-Branched Arylethylamine Backbones

Zhou, K., Zhu, Y., Fan, W., Chen, Y., Xu, X., Zhang, J., & Zhao, Y. (2019) · ACS Catalysis · doi:10.1021/acscatal.9b01347 · Cited by 57 · see citing works

Dual Photoredox/Nickel-Catalyzed Regioselective Cross-Coupling of 2-Arylaziridines and Potassium Benzyltrifluoroborates: Synthesis of β-Substitued Amines

Yu, X., Zhou, Q., Wang, P., Liao, C.-M., Chen, J., & Xiao, W. (2018) · Organic Letters · doi:10.1021/acs.orglett.7b03747 · Cited by 56 · see citing works

Branched Amine Synthesis via Aziridine or Azetidine Opening with Organotrifluoroborates by Cooperative Brønsted/Lewis Acid Catalysis: An Acid-Dependent Divergent Mechanism

Nguyen, T. N., & May, J. A. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b01394 · Cited by 55 · see citing works

Microbiota signatures relating to reduced memory and exploratory behaviour in the offspring of overweight mothers in a murine model

Sanguinetti, E., Guzzardi, M. A., Tripodi, M., Panetta, D., Selma-Royo, M., Zega, A., Telleschi, M., Collado, M. C., & Iozzo, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-48090-8 · Cited by 45 · see citing works

Pre-clinical Pharmacokinetic and Metabolomic Analyses of Isorhapontigenin, a Dietary Resveratrol Derivative

Dai, Y., Yeo, S. C. M., Barnes, P. J., Donnelly, L., Loo, L. C., & Lin, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00753 · Cited by 43 · see citing works

Aromatic Amino Acid Metabolites: Molecular Messengers Bridging Immune-Microbiota Communication

Shin, H., & Bang, Y.-J. (2025) · Immune Network · doi:10.4110/in.2025.25.e10 · Cited by 46 · see citing works

Simultaneous determination of twelve biogenic amines in serum by high performance liquid chromatography

Mao, H.-M., Chen, B.-G., Qian, X.-M., & Liu, Z. (2008) · Microchemical Journal · doi:10.1016/j.microc.2008.10.005 · Cited by 42 · see citing works

Nickel-Catalyzed Enantioselective C(sp3)–C(sp3) Cross-Electrophile Coupling of N -Sulfonyl Styrenyl Aziridines with Alkyl Bromides

Lan, Y., Han, Q., Liao, P., Chen, R., Fan, F., Zhao, X., & Liu, W. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c08435 · Cited by 35 · see citing works

Electrochemically‐Driven 1,4‐Aryl Migration via Radical Fluoromethylation of N‐Allylbenzamides: a Straightforward Access to Functionalized β‐Arylethylamines

Derat, É., Masson, G., & Claraz, A. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202406017 · Cited by 30 · see citing works

PSC-db: A Structured and Searchable 3D-Database for Plant Secondary Compounds

Valdés-Jiménez, A., Peña-Varas, C., Borrego-Muñoz, P., Arrué, L., Alegría‐Arcos, M., Nour‐Eldin, H. H., Drèyer, I., Núñez, G., & Ramírez, D. (2021) · Molecules · doi:10.3390/molecules26041124 · Cited by 25 · see citing works

Butterflies in the gut: the interplay between intestinal microbiota and stress

Lai, T.-T., Liou, C.-W., Tsai, Y.-H., Lin, Y.-Y., & Wu, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00984-6 · Cited by 25 · see citing works

Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: A meta-analysis

Yu, L., Qin, X. Y., Li, S., Zhang, X., He, Y., Peng, Q., Deng, Y., Wang, J., Xie, L., Li, T., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.05.033 · Cited by 24 · see citing works

No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population

Scordo, M. G., DAHL, M., Spina, E., Cordici, F., & Arena, M. G. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.10.005 · Cited by 19 · see citing works

Visible-Light-Mediated Radical Truce–Smiles Rearrangement via Arylazo Sulfones

Terlizzi, L. D., Nicchio, L., Montinho‐Inacio, E., Tiwari, N., Derat, É., Retailleau, P., Fagnoni, M., Neuville, L., Protti, S., & Masson, G. (2025) · JACS Au · doi:10.1021/jacsau.5c00919 · Cited by 13 · see citing works

Biogenic Amines in Cheese: Health Risks, Regulatory Perspectives, and Analytical Advances

Dankar, I., Eid, A., Hassan, H. F., & Serhan, M. (2025) · Journal of Food Processing and Preservation · doi:10.1155/jfpp/1925862 · Cited by 10 · see citing works

Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum

Hársing, L. G., Knoll, J. E., & Miklya, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158543 · Cited by 9 · see citing works

Detailed resume of S-methyltransferases: Categories, structures, biological functions and research advancements in related pathophysiology and pharmacotherapy

Mu, H., Ye, L., & Wang, B. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116361 · Cited by 8 · see citing works

Magic Blue-Initiated SN2-Type Ring Opening of Activated Aziridines: Friedel–Crafts-Type Alkylation of Electron-Rich Arenes/Heteroarenes

Kashyap, S., Singh, B., & Ghorai, M. K. (2024) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.4c01101 · Cited by 8 · see citing works

Biogenic Amines in Cheeses: Types and Typical Amounts

Barone, C., Barbera, M., Barone, M., Parisi, S., & Zaccheo, A. (2017) · Springer briefs in molecular science · doi:10.1007/978-3-319-65739-4_1 · Cited by 9 · see citing works

Palladium(II) – Catalyzed Functionalization of Aromatic Amines with Aliphatic Aziridines: Direct Approach to Form O‐Aminophenethylamine Backbones

He, S., Chen, Y., Huang, Z., Li, B., Shi, D., & Zhao, Y. (2022) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202101491 · Cited by 7 · see citing works

Tryptamine‐Derived Schiff Bases: Potent Antimicrobial Agents and Evaluation of Cytotoxicity, ADME and DNA Binding Properties

Marjanović, J. S., Petrović, N., Kosanić, M., Košarić, J. V., Mirić, A. N., Milivojević, N. N., Kostić, M. D., & Divac, V. M. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401699 · Cited by 6 · see citing works

Integrating host-microbiota metabolic networks: how aromatic amino acids shape immune homeostasis and affect disease progression

Zhang, Y.-N., Zhao, X., Wang, H.-R., Zhang, Z.-B., Shi, H., Wang, Y.-H., & Zhu, S. (2026) · Cellular & Molecular Immunology · doi:10.1038/s41423-026-01435-6 · Cited by 7 · see citing works

Multi-component Synthesis of 3-{3-[2-(1H-Indol-3-yl)ethyl]}-2,3-dihydro-2- (aryliminothiazol-4-yl)-2H-chromen-2-ones

Aychiluhim, T. B., & Rao, V. R. (2014) · Organic Preparations and Procedures International · doi:10.1080/00304948.2014.866469 · Cited by 5 · see citing works

Biocatalytic Decarboxylation of Aromatic l-Amino Acids with In Situ Removal of Both Products for Enhanced Production of Biogenic Amines

Han, S., Choi, Y.-R., & Shin, J. (2021) · Catalysis Letters · doi:10.1007/s10562-021-03535-6 · Cited by 5 · see citing works

Effect of orange juice and tryptamine on the behavior and c-fos expression of Wistar rats

Vázquez-Luna, A., García‐García, F., Contreras, D. I. C., Rivadeneyra-Domínguez, E., & Díaz-Sobac, R. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-018-0365-5 · Cited by 4 · see citing works

Presence of p-synephrine in teas commercialized in Porto Alegre (RS/Brazil)

Arbo, M. D., Braun, P., Leal, M. B., Larentis, E. R., Aboy, A. L., Bulcão, R., García, S. C., & Limberger, R. P. (2009) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502009000200012 · Cited by 4 · see citing works

Bee bread and gut microbiota

Zuluaga‐Domínguez, C. M., & Fuenmayor, C. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85400-9.00010-1 · Cited by 3 · see citing works

New probiotics: Dairy propionibacteria and the modulation of gut microbiota and physiology

Deutsch, S., & Jan, G. (2014) · HAL · Cited by 2 · see citing works

Effects of R-(-)-BPAP on the Expressions of Neurotrophins and Their Receptors in Mesencephalic Slices

Hirami, C., Takahata, K., Shimazu, S., Yoneda, F., Hayashi, K., Katsuki, H., & Akaike, A. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1524 · Cited by 2 · see citing works

A facile approach toward γ-branched amines via copper-catalyzed 1,3-aminoalkynylation and aminobromination of arylcyclopropanes

Bu, Y., ZHANG, Y. ‐., Shangguan, X., Sun, S., Li, Y., & Zhang, Q. (2024) · Tetrahedron Letters · doi:10.1016/j.tetlet.2024.154934 · Cited by 1 · see citing works

New Probiotics: Dairy Propionibacteria and the Modulation of Gut Microbiota and Physiology

(2014) · CRC Press eBooks · doi:10.1201/b16439-8 · Cited by 1 · see citing works

Trace Amines as Intrinsic Monoaminergic Modulators of Spinal Cord Functional Systems

Hochman, S., & Gozal, E. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803603-7.00010-0 · Cited by 1 · see citing works

Estudo do Transporte Celular da Sinefrina e da sua interacção com a Glutationa em Suspensões de Cardiomiócitos Isolados de Rato Adulto

Rossato, L. G. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Conclusion

(2005) · Springer eBooks · doi:10.1007/3-540-27434-0_7

Receptors of Mammalian Trace Amines

Lewin, A. H. (2008) · Springer eBooks · doi:10.1007/978-0-387-76678-2_20

Chemistry of N-sulfonated aziridines and their use in polymerization reactions

Elgemeie, G. H., Azzam, R. A., Zaghary, W. A., Aly, A. A., Metwally, N. H., Sarhan, M. O., Abdelhafez, E. M. N., & Elsayed, R. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822179-2.00001-x

Electrochemically‐Driven 1,4‐Aryl Migration via Radical Fluoromethylation of N‐Allylbenzamides: a Straightforward Access to Functionalized β‐Arylethylamines

Derat, É., Masson, G., & Claraz, A. (2024) · Angewandte Chemie · doi:10.1002/ange.202406017

Role of Trace Amines and Their Receptors in Neuroinflammation Development and Posttraumatic Spinal Cord and Brain Repair

Buglinina, A. D., Romanyuk, E. A., Milov, S. I., Chesnokov, A. A., Kalinina, D. S., & Евгеньевич, М. П. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s002209302501003x

Integrated Untargeted and Targeted Metabolomics Reveals Distinct Bioactive Metabolite Profiles Between Probiotic Supplements and Yogurt

Noh, S. H., Kim, S.-H., Kwon, H. T., & Lee, C. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052180

Hydroxylation et halogénation directe et sélective des composés azotés en milieu superacide

Mamontov, A. (2018) · doi:10.70675/5090c791z7015z4da1zb54ez972803624458

The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.

Gaszner, P., & Miklya, I. (2004) · PubMed · Cited by 2 · see citing works

The significance of selegiline/(−)-deprenyl after 50 years in research and therapy (1965–2015)

Miklya, I. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.127 · Cited by 39 · see citing works

Major depression and the synthetic enhancer substances, (−)-deprenyl and R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane

Gaszner, P., & Miklya, I. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.004 · Cited by 13 · see citing works

Structure–activity studies leading to (−)1-(Benzofuran-2-yl)-2-propylaminopentane, ((−)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of Catecholamines and Serotonin in the brain

Yoneda, F. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00002-5 · Cited by 40 · see citing works

A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain

Knoll, J. E., Baghy, K., Eckhardt, S., Ferdinandy, P., Garami, M., Hársing, L. G., Hauser, P., Mervai, Z., Pócza, T., Schaff, Z., et al. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.010 · Cited by 8 · see citing works